Wedbush Downgrades Replimune Group to Neutral, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Negative 89.8%

Neg 89.8% Neu 0% Pos 0%

Wedbush analyst Robert Driscoll downgrades Replimune Group (NASDAQ:REPL) from Outperform to Neutral and lowers the price target from $19 to $2.